ACRV
Acrivon Therapeutics, Inc.
Acrivon Therapeutics, Inc. (ACRV) has 21 SEC Form 4 filings (23 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jul 23, 2026.
- Industry:Biotechnology
- CEO:Peter Blume-Jensen
- Employees:75
- HQ:Watertown, MA, US
- IPO:2022-11-15
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1K
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$71.5M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Miller MaryFirst filing | Chief Legal Officer | Sale | 573 | $1K | Jul 23 | SEC ↗ |
Related companies
Acrivon Therapeutics, Inc. is in the Healthcare sector.